The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gene Therapy Medicinal Products (GTMP)-Global Market Insights and Sales Trends 2024
Synopsis
The global Gene Therapy Medicinal Products (GTMP) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gene Therapy Medicinal Products (GTMP) in various end use industries. The expanding demands from the Cancer, Monogenic, Infectious Disease and Cardiovascular Disease, are propelling Gene Therapy Medicinal Products (GTMP) market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Therapy Medicinal Products (GTMP), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Therapy Medicinal Products (GTMP) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Therapy Medicinal Products (GTMP) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Therapy Medicinal Products (GTMP) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Therapy Medicinal Products (GTMP) covered in this report include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc.
The global Gene Therapy Medicinal Products (GTMP) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Global Gene Therapy Medicinal Products (GTMP) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Therapy Medicinal Products (GTMP) market, Segment by Type:
Oral
Injection
Global Gene Therapy Medicinal Products (GTMP) market, by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Therapy Medicinal Products (GTMP) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Gene Therapy Medicinal Products (GTMP) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gene Therapy Medicinal Products (GTMP) in various end use industries. The expanding demands from the Cancer, Monogenic, Infectious Disease and Cardiovascular Disease, are propelling Gene Therapy Medicinal Products (GTMP) market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Therapy Medicinal Products (GTMP), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Therapy Medicinal Products (GTMP) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Therapy Medicinal Products (GTMP) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Therapy Medicinal Products (GTMP) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Therapy Medicinal Products (GTMP) covered in this report include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc.
The global Gene Therapy Medicinal Products (GTMP) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Global Gene Therapy Medicinal Products (GTMP) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Therapy Medicinal Products (GTMP) market, Segment by Type:
Oral
Injection
Global Gene Therapy Medicinal Products (GTMP) market, by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Therapy Medicinal Products (GTMP) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gene Therapy Medicinal Products (GTMP)
1.1 Gene Therapy Medicinal Products (GTMP) Market Overview
1.1.1 Gene Therapy Medicinal Products (GTMP) Product Scope
1.1.2 Gene Therapy Medicinal Products (GTMP) Market Status and Outlook
1.2 Global Gene Therapy Medicinal Products (GTMP) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2018-2029)
1.4 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Region (2018-2023)
1.5 Global Gene Therapy Medicinal Products (GTMP) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene Therapy Medicinal Products (GTMP) Market Size (2018-2029)
1.6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2018-2029)
1.6.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2018-2029)
1.6.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size (2018-2029)
1.6.4 Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2018-2029)
1.6.5 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size (2018-2029)
2 Gene Therapy Medicinal Products (GTMP) Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injection
2.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2018-2023)
2.2.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Type (2018-2029)
3 Gene Therapy Medicinal Products (GTMP) Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Monogenic
3.1.3 Infectious Disease
3.1.4 Cardiovascular Disease
3.1.5 Other
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2018-2023)
3.2.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Revenue Breakdown by Application (2018-2029)
4 Gene Therapy Medicinal Products (GTMP) Competition Analysis by Players
4.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2022)
4.3 Date of Key Players Enter into Gene Therapy Medicinal Products (GTMP) Market
4.4 Global Top Players Gene Therapy Medicinal Products (GTMP) Headquarters and Area Served
4.5 Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Therapy Medicinal Products (GTMP) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bluebird Bio
5.1.1 Bluebird Bio Profile
5.1.2 Bluebird Bio Main Business
5.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.1.4 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.1.5 Bluebird Bio Recent Developments
5.2 Sangamo
5.2.1 Sangamo Profile
5.2.2 Sangamo Main Business
5.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.2.4 Sangamo Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.2.5 Sangamo Recent Developments
5.3 Spark Therapeutics
5.3.1 Spark Therapeutics Profile
5.3.2 Spark Therapeutics Main Business
5.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.3.4 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.3.5 Dimension Therapeutics Recent Developments
5.4 Dimension Therapeutics
5.4.1 Dimension Therapeutics Profile
5.4.2 Dimension Therapeutics Main Business
5.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.4.4 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.4.5 Dimension Therapeutics Recent Developments
5.5 Avalanche Bio
5.5.1 Avalanche Bio Profile
5.5.2 Avalanche Bio Main Business
5.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.5.4 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.5.5 Avalanche Bio Recent Developments
5.6 Celladon
5.6.1 Celladon Profile
5.6.2 Celladon Main Business
5.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.6.4 Celladon Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.6.5 Celladon Recent Developments
5.7 Vical Inc.
5.7.1 Vical Inc. Profile
5.7.2 Vical Inc. Main Business
5.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.7.4 Vical Inc. Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.7.5 Vical Inc. Recent Developments
5.8 Advantagene
5.8.1 Advantagene Profile
5.8.2 Advantagene Main Business
5.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Products, Services and Solutions
5.8.4 Advantagene Gene Therapy Medicinal Products (GTMP) Revenue (US$ Million) & (2018-2023)
5.8.5 Advantagene Recent Developments
6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Therapy Medicinal Products (GTMP) Market Dynamics
11.1 Gene Therapy Medicinal Products (GTMP) Industry Trends
11.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
11.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
11.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
